{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:33:10Z","timestamp":1791891190437,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.lpm.2013.02.328","type":"journal-article","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T09:02:19Z","timestamp":1367139739000},"page":"e193-e201","source":"Crossref","is-referenced-by-count":122,"special_numbering":"P2","title":["Diagnosis, treatment and prognosis of Guillain-Barr\u00e9 syndrome (GBS)"],"prefix":"10.1016","volume":"42","author":[{"given":"Pieter A.","family":"van Doorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2013.02.328_bib0005","first-page":"1462","article-title":"Sur un syndrome de radiculo-n\u00e9vrite avec hyperalbuminose du liquide c\u00e9phalorachidien sans r\u00e9action cellulaire. Remarques sur les caract\u00e8res cliniques et graphiques des r\u00e9flexes tendineux","volume":"28","author":"Guillain","year":"1916","journal-title":"Bull Soc Med Hop Paris"},{"key":"10.1016\/j.lpm.2013.02.328_bib0010","first-page":"472","article-title":"Note sur la paralyse ascendente aigu\u00eb","volume":"6","author":"Landry","year":"1859","journal-title":"Gazette Hebdomadaire Med Chir"},{"key":"10.1016\/j.lpm.2013.02.328_bib0015","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.02.328_bib0020","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.02.328_bib0025","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0030","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"issue":"Suppl.","key":"10.1016\/j.lpm.2013.02.328_bib0035","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/WNL.53.2.409","article-title":"Residual physical outcome and daily living 3 to 6years after Guillain-Barr\u00e9 syndrome","volume":"53","author":"Bernsen","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.62.6.637","article-title":"Residual health status after Guillain-Barr\u00e9 syndrome","volume":"62","author":"Bernsen","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.02.328_bib0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0055","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain-Barr\u00e9 syndrome: a long-term follow-up study","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0060","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e31820e7b62","article-title":"Recognizing Guillain-Barr\u00e9 syndrome in preschool children","volume":"76","author":"Roodbol","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","article-title":"The immunobiology of Guillain-Barr\u00e9 syndromes","volume":"10","author":"Willison","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.02.328_bib0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpneuro0001","article-title":"Ganglioside complexes: new autoantibody targets in Guillain-Barr\u00e9 syndromes","volume":"1","author":"Willison","year":"2005","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbagen.2007.10.001","article-title":"Antibodies against gangliosides and ganglioside complexes in Guillain-Barr\u00e9 syndrome: new aspects of research","volume":"1780","author":"Kusunoki","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lpm.2013.02.328_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.05.020","article-title":"Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome)","volume":"215","author":"Yuki","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.lpm.2013.02.328_bib0090","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1086\/513800","article-title":"Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barr\u00e9 syndrome and Miller Fisher syndrome","volume":"176","author":"Yuki","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2013.02.328_bib0095","first-page":"3","article-title":"Anti-ganglioside antibody and neuropathy: review of our research","volume":"3","author":"Yuki","year":"1998","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.02.328_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barr\u00e9 syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2013.02.328_bib0110","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barr\u00e9 syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome","volume":"67","author":"Walgaard","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0120","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome","volume":"35","author":"The Guillain-Barr\u00e9 syndrome Study Group","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids","volume":"22","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.02.328_bib0135","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.02.328_bib0140","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"7","author":"Raphael","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.02.328_bib0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome","volume":"41","author":"The French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0150","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"Van Der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.02.328_bib0155","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"7","author":"Hughes","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.02.328_bib0160","first-page":"586","article-title":"Double-blind trial of intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome","volume":"341","author":"Guillain-Barr\u00e9 Syndrome Steroid Trial Group","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.02.328_bib0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.02.328_bib0170","first-page":"CD001446","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"8","author":"Hughes","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.02.328_bib0175","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/jnnp.2006.102731","article-title":"Treatment of Guillain-Barr\u00e9 syndrome with mycophenolate mofetil: a pilot study","volume":"78","author":"Garssen","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.02.328_bib0180","first-page":"CD004761","article-title":"Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders","volume":"1","author":"Overell","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.02.328_bib0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1586\/ern.11.182","article-title":"Fisher syndrome: clinical features, immunopathogenesis and management","volume":"12","author":"Mori","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.lpm.2013.02.328_bib0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11940-010-0103-8","article-title":"Fisher syndrome","volume":"13","author":"Mori","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0195","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.wnl.0000258673.31824.61","article-title":"Intravenous immunoglobulin therapy for Miller Fisher syndrome","volume":"68","author":"Mori","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0200","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(97)24050-X","article-title":"Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barr\u00e9 syndrome","volume":"350","author":"Farcas","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.02.328_bib0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.21737","article-title":"Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barr\u00e9 syndrome","volume":"66","author":"Kuitwaard","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0210","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barr\u00e9 syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.wnl.0000167549.09664.b8","article-title":"Distinguishing acute-onset CIDP from Guillain-Barr\u00e9 syndrome with treatment-related fluctuations","volume":"65","author":"Ruts","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0220","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/jnnp.54.11.957","article-title":"Treatment related fluctuations in Guillain-Barr\u00e9 syndrome after high-dose immunoglobulins or plasma-exchange","volume":"54","author":"Kleyweg","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.02.328_bib0225","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Distinguishing acute-onset CIDP from fluctuating Guillain-Barr\u00e9 syndrome: a prospective study","volume":"74","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1529-8027.2008.00197.x","article-title":"Pain accompanies pure motor Guillain-Barr\u00e9 syndrome","volume":"13","author":"Ruts","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.02.328_bib0235","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pain.2011.10.037","article-title":"Unmyelinated and myelinated skin nerve damage in Guillain-Barr\u00e9 syndrome: correlation with pain and recovery","volume":"153","author":"Ruts","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.lpm.2013.02.328_bib0240","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1212\/WNL.53.8.1648","article-title":"Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group","volume":"53","author":"Merkies","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0245","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1212\/01.WNL.0000148589.87107.9C","article-title":"Physical training and fatigue, fitness, and quality of life in Guillain-Barr\u00e9 syndrome and CIDP","volume":"63","author":"Garssen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.02.328_bib0250","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1474-4422(06)70603-2","article-title":"Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr\u00e9 syndrome: a prospective study","volume":"5","author":"Durand","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0255","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome","volume":"6","author":"van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0260","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.02.328_bib0265","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jclinepi.2010.05.003","article-title":"Covariate adjustment increases statistical power in randomized controlled trials","volume":"63","author":"Lingsma","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lpm.2013.02.328_bib0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1529-8027.2008.00169.x","article-title":"Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials","volume":"13","author":"van Nes","year":"2008","journal-title":"J Peripher Nerv Syst"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T11:28:25Z","timestamp":1715254105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498213005058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0755498213005058"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.02.328","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}